Table 2.
Cohort overview
Control | Intervention | p value | |
---|---|---|---|
Patients | 2389 | 2394 | |
Encounters | 2523 | 2521 | |
Gender | 811 F (32.1%) | 813 F (32.2%) | 0.94 |
Clinical unit (GICU) | 1055 (41.8%) | 1120 (44.4%) | 0.06 |
Age | 63.6 (14.5) years | 63.0 (15.1) years | 0.15 |
ICU LOS | 5.8 (6.7) days | 5.9 (6.0) days | 0.58 |
RRT | 163 (6.5%) | 200 (7.9%) | 0.04 |
Readmissions | 46 (1.8%) | 81 (3.2%) | 0.002 |
Weight (kg) | 81.0 (20.0) | 84.7 (20.9) | < 0.001 |
Race (Black) | 33 (1.3%) | 81 (3.2%) | < 0.001 |
Baseline creatinine measured | 41 (1.63%) | 1463 (58.03%) | < 0.001 |
Encounters with SCr measurements | 2523 (100%) | 2516 (99.8%) | 0.025 |
Encounters with UO measurements | 2437 (96.6%) | 2426 (96.2%) | 0.49 |
Encounters with weight measurements | 2406 (95.4%) | 1829 (72.6%) | < 0.001 |
The table compares the control and intervention cohort demographics and data availability. Data are presented as: for binary variables—count (percentage of admissions) and for continuous variables—mean (standard deviation). Details of p value calculation are provided in Methods and statistically significant differences are highlighted in italics font. See ‘Results’ section for details